Open AccessAcyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial
Author(s) -
Sanjay Singh,
Narendra Kumar Tiwary
Publication year - 2016
Publication title -
indian journal of dermatology venereology and leprology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.514
H-Index - 45
eISSN - 0973-3922
pISSN - 0378-6323
DOI - 10.4103/0378-6323.182791
Subject(s) - pityriasis rosea , placebo , medicine , confidence interval , randomized controlled trial , erythema , dermatology , pathology , alternative medicine
Acyclovir is considered to be an effective treatment for pityriasis rosea but randomized, blinded, placebo-controlled trials have not been performed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom